Evidence map›Paper›PMID 29301276›Full record

ArticleInternational journal of molecular sciences2018

Rosiglitazone as a Modulator of TLR4 and TLR3 Signaling Pathways in Rat Primary Neurons and Astrocytes.

Dmitry V Chistyakov, Nadezda V Azbukina, Alexandr V Lopachev, Ksenia N Kulichenkova, Alina A Astakhova, Marina G Sergeeva

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Hypoxia Induces Astrocyte-Derived Lipocalin-2 in Ischemic Stroke.International journal of molecular sciences · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Dmitry V ChistyakovBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow 119992, Russia. Chistyakof@gmail.com.
Nadezda V AzbukinaFaculty of Bioengineering and Bioinformatics, Moscow Lomonosov State University, Moscow 119234 Russia. ridernadya@gmail.com.
Alexandr V LopachevResearch Center of Neurology, Moscow 125367, Russia. lopsasha@yandex.ru.
Ksenia N KulichenkovaResearch Center of Neurology, Moscow 125367, Russia. koulitchenkova@gmail.com.ORCID 0000-0002-2773-7526
Alina A AstakhovaBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow 119992, Russia. alina.an.astakhova@gmail.com.
Marina G SergeevaBelozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow 119992, Russia. mg.sergeeva@gmail.com.
Lomonosov Moscow State University · RUResearch Center of Neurology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An antidiabetic drug of the thiazolidinedione class, rosiglitazone (RG) demonstrates anti-inflammatory properties in various brain pathologies. The mechanism of RG action in brain cells is not fully known. To unravel mechanisms of RG modulation of toll-like receptor (TLR) signaling pathways, we compare primary rat neuron and astrocyte cultures stimulated with the TLR4 agonist lipopolysaccharide (LPS) and the TLR3 agonist poly I:C (PIC). Both TLR agonists induced tumor necrosis factor (TNFα) release in astrocytes, but not in neurons. Neurons and astrocytes released interleukin-10 (IL-10) and prostaglandin E2 (PGE₂) in response to LPS and PIC. RG decreased TLR-stimulated TNFα release in astrocytes as well as potentiated IL-10 and PGE₂ release in both astrocytes and neurons. RG induced phosphorylation of p38 and JNK MAPK (mitogen-activated protein kinase) in neurons. The results reveal new role of RG as a modulator of resolution of neuroinflammation.

Indexed as

AnimalsAstrocytesCells, CulturedCerebral CortexDinoprostoneInterleukin-10JNK Mitogen-Activated Protein KinasesNeuronsp38 Mitogen-Activated Protein KinasesPhosphorylationRats, WistarRosiglitazoneSignal TransductionThiazolidinedionesToll-Like Receptor 3Toll-Like Receptor 4DinoprostoneInterleukin-10JNK Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesRosiglitazoneThiazolidinedionesToll-Like Receptor 3Toll-Like Receptor 4Tumor Necrosis Factor-alphainterleukin-10 (IL-10)lipopolysaccharide (LPS)mitogen-activated kinase (MAPK)poly I:C (PIC)rosiglitazone (RG)thiazolidinedione (TZD)toll-like receptor (TLR)tumor necrosis factor alpha (TNFα)

Identifiers

PMID29301276
PMCPMC5796062
OpenAlexW2781904813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.